This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Seligmann, J. F. et al. Combined epiregulin and amphiregulin expression levels as a predictive biomarker for panitumumab therapy benefit or lack of benefit in patients with RAS wild-type advanced colorectal cancer. JAMA Oncol. http://dx.doi.org/10.1001/jamaoncol.2015.6065 (2016)
Rights and permissions
About this article
Cite this article
Killock, D. PICCOLO — changing the tune of anti-EGFR therapy. Nat Rev Clin Oncol 13, 202–203 (2016). https://doi.org/10.1038/nrclinonc.2016.32
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2016.32